What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
As you snack on turkey sandwiches and leftover pumpkin pie, check out the articles highlighted by the editors of...
November is National Family Caregivers Month, which honors the role of caregivers in communities. The book “Already Toast: Caregiving...
The American Association for Cancer Research (AACR) is proud to announce a new collaboration with a grants program aimed at...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, has been honored with the...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
For the past three years, cohorts of talented young researchers from around the world have participated in the AACR Annual...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
AACR on Campus – Defeating Cancer through Global Education and Training is a global outreach program that will bring...
While cancer and COVID-19 are, biologically, very different diseases, they have shaken the world in surprisingly similar ways. Nearly...